NCT00003445View on ClinicalTrials.gov

Docetaxel in Treating Patients With Advanced Cancer of the Cervix

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 1997

Study Completion Date

April 30, 2004

Conditions

Cervical Cancer

Interventions

DRUG

docetaxel

Trial Locations (1)

8300

Unidad Oncologica Del Comahue, Neuquén

All Listed Sponsors

lead

Grupo Oncologico Cooperativo del Sur

OTHER

NCT00003445 - Docetaxel in Treating Patients With Advanced Cancer of the Cervix | Biotech Hunter | Biotech Hunter